Collectively the revenues generated by statin cholesterol lowering drugs, like Lipitor, Crestor, Zocor, and Pravachol are in excess of 10 billion dollars a year! Is taking these drugs a risk unto itself? The answer is a resounding….YES! Though these drugs are shown to reduce certain cardiovascular risks in people who have cardiovascular risk factors such as; hypertension, low HDL cholesterol, insulin resistance, high triglycerides, physicians are now recommending these drugs to people who don’t have any of these risks...